<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Comparison of glucocorticoid preparations used for treatment of adrenal insufficiency in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Comparison of glucocorticoid preparations used for treatment of adrenal insufficiency in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Comparison of glucocorticoid preparations used for treatment of adrenal insufficiency in children</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Glucocorticoids</td> <td class="subtitle1_left">Glucocorticoid activity relative to hydrocortisone*</td> <td class="subtitle1_left">Mineralocorticoid activity<sup>¶</sup></td> <td class="subtitle1_left">Plasma half-life <span class="nowrap_whitespace">(min)<sup>[1]</sup></span></td> </tr> <tr> <td class="subtitle2_left_white" colspan="4">Short-acting</td> </tr> <tr> <td class="indent1">Hydrocortisone (cortisol)</td> <td>1</td> <td>Moderate</td> <td>60 to 90</td> </tr> <tr> <td class="subtitle2_left_white" colspan="4">Intermediate-acting</td> </tr> <tr> <td class="indent1">Prednisone</td> <td>5</td> <td>Low</td> <td>60</td> </tr> <tr> <td class="indent1">Prednisolone</td> <td>5</td> <td>Low</td> <td>115 to 200</td> </tr> <tr> <td class="subtitle2_left_white" colspan="4">Long-acting</td> </tr> <tr> <td class="indent1">Dexamethasone</td> <td>60 to 80</td> <td>None</td> <td>200</td> </tr> <tr> <td class="subtitle1_left">Mineralocorticoids</td> <td class="subtitle1_left">Dose</td> <td class="subtitle1_left">Mineralocorticoid activity<sup>¶</sup></td> <td class="subtitle1_left">Plasma half-life <span class="nowrap_whitespace">(min)<sup>[1]</sup></span></td> </tr> <tr> <td>Fludrocortisone</td> <td>0.1 to 0.2 mg<sup>Δ</sup></td> <td>High</td> <td>200</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>* In this table, glucocorticoid activity refers to the relative effect as measured by <strong>growth suppression</strong>, which is thought to be the best measure of potency for patients with adrenal <font class="nowrap_whitespace">insufficiency<sup>[1-4]</sup>.</font> The relative potency for antiinflammatory effects is somewhat lower.</p>
<p>¶ 20 mg of hydrocortisone and 25 mg of cortisone acetate each provide a mineralocorticoid effect that is approximately equivalent to 0.1 mg <font class="nowrap_whitespace">fludrocortisone<sup>[5]</sup>.</font></p>
Δ For patients with mineralocorticoid deficiency, the typical daily dose of fludrocortisone is 0.1 mg when given in conjunction with hydrocortisone (which has some mineralocorticoid activity). The dose is adjusted as needed to achieve normal plasma renin activity. It is not adjusted by weight, age, or body surface area, because the aldosterone secretion rate is nearly constant throughout the lifespan. Higher doses are occasionally needed in early infancy (eg, &lt;4 months of age) due to physiologic resistance of the immature kidney to mineralocorticoid.</div><div class="graphic_reference">References:
<ol>
<li>Finkielstain GP, Kim MS, Sinaii N, et al. Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2012; 97:4429.</li>
<li>Nicolaides NC, Pavlaki AN, Alexandra M, Chrousos GP. Endotext: Glucocorticoid Therapy and Adrenal Suppression. 2018. Available at: <a href="https://www.ncbi.nlm.nih.gov/books/NBK279156/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK279156/</a> (Accessed on August 16, 2022).</li>
<li>Hindmarsh PC. Management of the child with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009; 23:193.</li>
<li>Rivkees SA, Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 2000; 106:767.</li>
<li>Miller WL, Fluck CE, Breault DT, Feldman BJ. The adrenal cortex and its disorders. In: Sperling Pediatric Endocrinology, 5th ed, Sperling MA, Majzoub JA, Menon RK, Stratakis CA (Eds), Elsevier 2020.</li>
</ol></div><div id="graphicVersion">Graphic 139399 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
